Gene therapy provides a promising approach to curing diabetes. However, an effective route for islet-specific targeting has yet to be established. Toward this end, the pancreatic blood circulation system in Balb/c mice was determined by the injection of rhodamine-containing beads. The efficiency of islet targeting was then measured by the injection of adenoviral vectors carrying a green fluorescence gene via the celiac trunk (C.T.). The results showed that >95% of islets and about 60% of β cells within the pancreatic body and tail could be labeled 3 days after surgery. α-Cell labeling was not as efficient, whereas labeling of nonendocrine tissues was barely detectable. For proof of principle, adenoviral vectors carrying a Sirtuin transgene were injected similarly to test the islet protection effect in the streptozotocin (STZ)-induced type 1 diabetic model. The results demonstrated that overexpression of Sirtuin in STZ-treated mice reduced the level of β-cell death and extent of glucose intolerance. This study reports on efficient isletspecific targeting by using adenoviral injection. This procedure could be invaluable to the treatment of diabetes and the study of islet biology.
IntroductIon
Gene therapy has the potential to cure type 1 diabetes by preventing autoimmunity, or by stimulating β-cell regeneration.
1 Several viral vectors including adenovirus, adeno-associated virus, and lentivirus have been used to transfer genes into the pancreas in vivo. [2] [3] [4] [5] However, an effective route to achieving islet-specific targeting has not been established. Direct injection of adenoviruses into the pancreatic parenchyma largely led to transduction of the exocrine tissue. 6 On the other hand, retrograde pancreatic duct injection limited viruses within the ductal system. A small degree of leakiness of viruses into the interstices, however, could occur when a strong injection force was applied. 7, 8 It has been shown that pancreatic islets have fenestrated capillaries with pores of 50-80 nm in diameter, whereas the capillaries in other pancreatic tissues have continuous sealed endothelia. 9, 10 Taking advantage of this unique feature, Ayuso et al. reported an adenoviral injection procedure through the jugular vein (J.V.) which targeted specifically the pancreatic β cells. 11 Other tissues such as the glomerulus, lung, spleen, and kidney were also affected to a certain degree. 12 However, we failed to reproduce the reported result of a significant islet labeling. 11 Therefore, it could be important to develop a local administration route via the celiac trunk (C.T.).
Sirt1 is a histone deacetylase and belongs to the silent information regulator (Sir2) family. 13 Recent studies have shown that Sirt1 could inhibit the transcriptional nuclear factor-κB signaling pathway by direct deacetylation of the p65 subunit, 14 and could downregulate the levels of inducible form of nitric oxide synthase and nitric oxide production, 15 which was an essential component of the inflammatory response that caused β-cell destruction. 16 Furthermore, treatment with the β-cell-specific toxin, streptozotocin (STZ), could rapidly increase the nuclear translocation of nuclear factor-κB subunits and the production of inducible form of nitric oxide synthase. 17 Activation of Sirt1, therefore, protected β cells from apoptosis in STZ-treated mice. 17 The results in this study showed that β-cell-specific labeling could be accomplished with high efficiency by adenoviral vectors injected via the C.T. Furthermore, overexpression of Sirt1 protected β cells from apoptosis in STZ-treated mice. This procedure could be invaluable to the treatment of diabetes and the study of islet biology.
results

Blood circulation and injection route
After anesthesia, the abdomen of Balb/c mouse was open through a midline incision. The duodenum and the pancreatic head were flipped over to the left, to expose the underneath circulation system (Figure 1a) . To determine the pancreatic blood supply, we injected rhodamine-containing beads into different arteries while occluding the C.T. and portal vein. We found that the pancreatic body and tail were supported by the lieno-pancreatic artery. Due to the complexity of the pancreatic blood circulation, it was difficult to perfuse the whole parenchyma with a single procedure. Therefore, we chose the islet-abundant pancreatic body and tail To optimize the delivery efficiency, the pancreatic blood-inlet was blocked and, subsequently, the blood-outlet was occluded so that empty space for accommodation of the vectors could be created (Figure 1b) . By using rhodamine-containing beads, we found that clamping the C.T. for at least 2 minutes was necessary to empty the pancreatic blood. Ligations of the proximal end of the common hepatic artery and gastro-lienal artery, and distal end of the lieno-pancreatic artery resulted in a fully perfused pancreas by preventing temporarily the beads from going into the liver, stomach, and spleen. In addition, placing a ligation on the pancreatic vein led to a great retention of beads within the pancreas.
Having established the procedure, we compared the effectiveness of bead delivery into the pancreas via two injection routes: the C.T., established in this study, versus the J.V. reported previously in the literature. 11 As shown in Figure 2a , the intensity of rhodamine within the C.T.-pancreas detected directly under a fluorescence microscope was dramatically brighter than that of J.V.-pancreas. In addition, capillaries by the edges of pancreatic lobes were clearly illuminated. Moreover, C.T.-pancreas displayed a few bright red speckles probably revealing the locations of a subset of islets. The preferential retention of beads within islets was verified by immunofluorescence staining (Figure 2b) . transduction efficiency of islet β cells A density of 5 × 10 9 infection units (IU) of adenoviral vectors carrying a gene for the green fluorescence protein (Ad-EGFP) were then injected via C.T. or J.V. Pancreases were harvested 3 days after operation. Consistent with the result of bead injection, Ad-EGFP injected C.T.-pancreas displayed many big fluorescence clusters comparable to the size of an islet, while J.V.-pancreas showed only a few smaller fluorescence spots (Figure 3a) . On the other hand, higher fluorescence intensity could be detected in the liver and spleen of J.V.-mice (Supplementary Figure S1a,b) .
Immunofluorescence analyses were carried out to identify the transduced pancreatic cell types (Figure 3b) . In both C.T.-and J.V.-pancreases, the result showed that EGFP-positive cells resided exclusively within islets. Quantification analyses showed that labeling efficiencies for islets and β cells were ~85 and 30%, respectively, in C.T.-pancreases as compared to that of <20 and 5% in J.V.-pancreases (Figure 4a) . In contrast, J.V. injection led to a more efficient transduction of liver cells and spleen cells (Supplementary Figure S1c, We then tested the dose-dependent adenoviral transduction efficiency of pancreatic β cells. The results showed that as low as 1 × 10 9 IU of viruses were able to label about 60% of islets and 5% of β cells. When 2.5 × 10 10 IU of viruses were injected, the transduction efficiency increased to >95 and 60% for islets and β cells, respectively (Figure 4b) . transduction efficiency of islet α cells Curiously, we found that α-cell targeting was inefficient as compared to that of β cells (Figure 3c ). To test whether this was due to a selective tropism of adenovirus toward β cells, we carried out a a b .
. suspension culture with isolated islets in the presence of Ad-EGFP.
The ex vivo result showed that α cells could be transduced efficiently by adenoviral vectors, indicating the existence of a possible physical barrier between α cells and islet capillaries (Figure 4c) . Alternatively, it has been proposed that the opening of capillaries within islets could be controlled by "gates" consisting of endothelial cells in response to plasma glucose levels. 18 Therefore, glucose was injected into the peritoneal cavity 30 minutes in advance of the vector injection. However, the ratio of transduction percentage between β and α cells was not correlated to the variation of glucose concentration (Figure 4c) .
expression of sirt1 protected islet β cells
For proof of principle, we tested the islet protective function of Sirt1 in STZ-treated mice. Three days after the injection of Ad-Sirt1 (5 × 10 9 IU) via C.T., the expression of Sirt1 in islets increased dramatically as compared to that of Ad-EGFP-injected controls (Figure 5a) . Consequently, intraperitoneal injection of STZ led to severe β-cell death in Ad-EGFP, but mild in Ad-Sirt1-treated mice (Figure 5b and Supplementary Figure S4 and Supplementary Materials and Methods). Islet cell mass in Ad-EGFP-treated mice was reduced to ~20% of normal mice 3 days after STZ injection. However, about 40% of islet cell mass was maintained in Ad-Sirt1-treated mice (Figure 6a) . Furthermore, the residual β cells were mostly EGFP-positive and Sirt1-positive, confirming an essential role of Sirt1 on β survival (Figure 5c ). On the contrary, β-cell mass was not preserved in Ad-Sirt1-treated mice when the vector was injected via J.V. (Supplementary Figure S5a) .
Finally, we tested the function of islets in Ad-Sirt1-treated mice. The fasting glucose levels were significantly increased in Ad-EGFP mice 24 hours after STZ treatment. On the contrary, Ad-Sirt1-treated mice via C.T., but not via J.V., maintained euglycemia before and after STZ injection (Figure 6b and Supplementary  Figure S6a) . However, the administration of STZ apparently led to mild glucose intolerance in Ad-Sirt1-treated C.T.-mice although neither as severe as that in Ad-EGFP-treated mice (Figure 6c .
In vivo Ex vivo
. 
dIscussIon
An effective route to achieving islet-specific targeting in vivo is key to the success of gene therapy for diabetes. Systematic administration from the J.V. reportedly transduced >20% of islet cells with 5 × 10 8 plaque-forming unit of adenoviral vectors. 11 However, the result was not repeated in this study. We noticed that the adenovirus of serotype 2, instead of serotype 5, was used in the reported study. 11 However, adenoviral vector of serotype 5 has been shown to transduce a broad spectrum of cell types including islet β cells. 19 Nevertheless, we reasoned that local delivery could be more favorable as systemically injected viral particles might be neutralized by the complement, or opsonized by the macrophage. In addition, high loads of viral particles in the circulation inevitably would provoke a strong immune response. 20 Bead injection via C.T. showed a characteristic speckle pattern within the pancreas, probably revealing the locations of a subset of islets (Figure 2b) . This is consistent with the disproportional distribution of blood supply to pancreatic islets, which constitute <2% of the pancreatic cell mass and yet consume ~20% of the arterial blood volume. 21 Furthermore, a previous study using electromicroscopy showed that islets, especially interlobular ones, could be easily distinguished from the exocrine tissue due to the presence of prominent vessels. 22 However, we did notice that the speckles were not evenly distributed in the pancreas. We are not sure presently whether this reflects different perfusion features of individual islets, or whether our procedure needs further improvement.
Not surprisingly, Ad-EGFP injection via C.T. showed a much brighter speckle pattern; though, the highly specific transduction of islet cells was unexpected (Figure 3b) . In contrast to the sealed and continuous endothelium in the exocrine tissue, intraislet capillaries were lined by fenestrated endothelial cells, which had a pore size in the range of 50-80 nm in diameter. 9, 10 Adenovirus of serotype 5 with a particle size of ~80 nm probably has the capability to emigrate from the pore with the help of blood pressure or the pressure created during viral injection.
Additional specificity might be provided by the basement membrane that has been found to function as a physical barrier for the islets. 23 Viral particles, apparently coming out off capillaries, were trapped within islet capsules consisting of many components of the extracellular matrix. The possibility of a selective tropism of the adenoviral vectors could be ruled out. Studies from our lab and others had demonstrated that acinar and ductal cells could be labeled efficiently when adenoviral vectors were injected into the duct or directly into the parenchyma. 7, 8 However, a physical nature probably was not accountable for the lack of targeting of the vessel endothelial cells, suggesting a longer duration in the lumen might be necessary, or that endothelial cells were intrinsically inert to adenoviral transduction in vivo. 24 Here, the study also found a bias against α-cell targeting. The result from the ex vivo study clearly pointed to a physical explanation (Figure 3c) . Each islet was vascularized by 1-5 arterioles that eventually branched into a spherical structure similar to a glomerulus. 25 In rodents, β cells usually resided in the center, whereas α cells located primarily around the periphery of islets. 26 Higher β-cell specificity, therefore, was consistent with the hypothesis that β cells were perfused first. 27 Alternatively, β cells might stimulate a more active vasogenesis as β cells expressed more angiogenic factors than α cells. 28 Finally, the result in this study argued against the existence of "capillary gates" controlling blood perfusion to subsets of islet cells according to plasma glucose levels (Figure 4c) .
Nevertheless, the results demonstrated that β-cell targeting could be accomplished with high specificity and high efficiency by a local adenoviral injection procedure (Figure 4b) . As low as 1 × 10 9 IU of viruses were able to label about 60% of islets and 5% of β cells. This number increased to >95 and 60%, respectively, when 2.5 × 10 10 IU of viruses were injected. Of note, the titration method used in this study might result in a much superficially higher IU than that of plaque-forming unit (AdEasy manual, Stratagene, La Jolla, CA). It was also noteworthy that minimal cytotoxicity and inflammation were detected within islets.
Although a local arterial perfusion is difficult to perform in small animal models, the development of a straightforward approach in the mouse is very important as most of the resources are available in this species. Our procedure appeared quite invasive; however, around 70% of mice survived and looked healthy. When the animals were killed 3 days after surgery, the pancreas, liver, spleen, and stomach were in normal shape and color (Supplementary Figure S1a,b) . Intra-arterial techniques have been published for the treatment of muscle disease, liver cancer, and brain tumor. [29] [30] [31] In these studies, small molecule drug, naked plasmid DNA, recombinant adeno-associated virus, and even stem cells were able to diffuse or migrate into the targeted organs. [29] [30] [31] [32] [33] Intra-arterial injection of DNA-containing liposomes has also been reported to transfect endothelial cells, and occasionally acinar cells, but not endocrine cells in the pancreas. 34 In bigger animal, Tal et al. have successfully performed surgeries in nonhuman primates, in which the β-cell-specific STZ was injected via a percutaneous access of the common femoral artery. 35 Therefore, the technique established in this study might have great potentials for the treatment of diabetes and other pancreatic diseases.
Finally, to prove this concept, we tested the β-cell protection effect of Sirt1 in STZ-treated mice. Sirt1 is a multifunctional protein deacetylase capable of stimulating insulin secretion by repressing the expression of the uncoupling protein 2, and reducing β-cell death by downregulating the proapoptotic nuclear factor-κB signaling, which could be induced by the treatment of STZ or inflammatory cytokines (Supplementary Figure S3 and Supplementary Materials and Methods). 13, 17 Ad-Sirt1 injection via C.T. dramatically increased its expression levels in islets and, therefore, protected a portion of β cells from STZ-induced apoptosis (Figures 5 and 6a; Supplementary Figure S4) . Apparently, the residual β cells in Ad-Sirt1 mice were able to maintain euglycemia under fasting condition, but were not enough to preserve normal glucose kinetics when a large amount of glucose was injected (Figure 6b,c) . Transduction of hepatocytes with Ad-Sirt1 probably had no effect on glucose metabolism (Supplementary  Figure S6c) . We are currently testing the islet targeting via C.T. using lentiviral vectors that may provide a long-term protection effect. In summary, we described an efficient intra-arterial technique to target specifically islet β cells by adenoviral injection via the C.T.. This approach could be important to the treatment of diabetes as well as to the study of islet biology in the future.
MAterIAls And Methods
Animals and materials. Eight-to 12-week-old Balb/c mice were purchased from the Shanghai Laboratory Animal Company (Shanghai, China) and raised in our specific pathogen-free and air-conditioned animal facility. Mice were fed ad libitum with a standard diet (Shanghai Laboratory Animal Company) and kept under a light-dark cycle of 12 hours. Animal care and experimental procedures were in compliance with the guidelines for the use and care of laboratory animals established by Shantou University.
Biochemical reagents and antibodies were purchased from the companies indicated below: 4′,6-diamidino-2-phenylindole (Dojindo, Kumamoto, Japan); rabbit anti-EGFP (Beyotime, Shanghai, China); rabbit anti-Sirt1, mouse anti-Pan-CK, mouse anti-amylase, and goat anti-insulin (Santa Cruz, Santa Cruz, CA); mouse anti-glucagon (Boster, Wuhan, China); FITC-conjugated goat anti-rabbit IgG (Boster); Cy3-conjugated sheep anti-mouse IgG (Sigma, St Louis, MO); mounting fluid (Applygen, Beijing, China); collagenase (type IV), and STZ (Sigma); rhodaminecontaining beads with a size of 100-200 μm were kindly provided by Yucui Xiong. 36 All other reagents were of analytical grade.
Recombinant adenoviral vectors.
The E1-deleted adenovirus (serotype 5) carrying the cytomegalovirus promoter/EGFP hybrid gene was purchased from Vector Gene Technology.(Beijing, China). For amplification of the Ad-EGFP viruses, 1 × 10 8 IU of viruses were added into a 10-cm dish preseeded with 1 × 10 6 Ad293 cells (Stratagene, La Jolla, CA) overnight. After incubation for 30-48 hours, the cells were harvested by scrapping and centrifugation at 3,000 r.p.m. for 10 minutes, while the supernatant was saved for the next round of virus amplification. The harvested cells underwent four freeze/thaw cycles and were spun at 12,000g for 10 minutes to obtain cell lysates. Serial dilutions of the supernatant and cell lysates were used to transduce Ad293 cells in a 96-well plate preseeded with 5,000 cells overnight. The viral titers (IU) were determined by counting EGFP-positive cells under a fluorescence microscope after 30-hour cultivation. The construct containing the Sirt1 gene was kindly provided by Qiwei Zhai. 37 Sirt1 was subcloned into the shuttle vector pAdTrack (which carries an EGFP Intra-arterial Delivery of Ad-Sirt1 to Islets reporter under the control of a cytomegalovirus promoter; Stratagene) for the generation of Ad-Sirt1 according to the procedure provided by the company. The amplification and titration of Ad-Sirt1 was the same as described above.
Surgical procedures. Balb/c mice were fasted for 12 hours before being anesthetized by an intraperitoneal injection of sodium barbital (10 mg/kg; Sigma). Laparotomy was performed through a midline abdominal incision. The duodenum and the head of the pancreas were flipped over to the left, to expose the underneath circulation system. Rhodamine-containing beads, or adenoviral vectors, in 50 μl of saline solution were injected according to one of the following two procedures.
C.T.:
The proximal end of the C.T. was clamped with a hemostatic forceps for 2 minutes. After that, three ligations were placed sequentially on the proximal end of the common hepatic artery and lieno-gastric artery, distal end of lieno-pancreatic artery, and pancreatic vein with 5-0 sutures. The beads or adenoviral vectors were then injected with a 31G insulin needle (BD, Franklin Lakes, NJ) via the C.T. The ligation at the common hepatic artery and lieno-gastric artery was then removed. The bleeding was stopped by pressing down a cotton swap on the site of injection for 5 minutes after releasing the forceps. The ligations at the distal end of the lieno-pancreatic artery and pancreatic vein were maintained for another 15 minutes before the abdominal wall was closed with sutures.
J.V.: Adenoviral vectors were injected via the J.V. with a hepatic ligation according to a previously reported procedure.
11 Animals were killed 3 days after the administration of Ad-EGFP. The pancreas, liver, and spleen were harvested and examined directly under a fluorescence microscope (Supplementary Figure S1) . The pancreatic tails were embedded in paraffin and processed for immunostaining analysis. For animals injected with beads, the pancreases were visualized directly under a fluorescence microscope without removal of the ligations. The pancreatic body and tail were then embedded in OCT (Sakura Finetek, Torrance, CA) for frozen sectioning.
Islet purification and viral infection.
The procedure for islet isolation has been described previously. 8 Briefly, 2 ml of 0.5% type IV collagenase was injected into the pancreas via the pancreatic duct. The pancreas was then harvested and chopped into small pieces before being digested in a 37 °C water bath for about 10 minutes. The enzyme was inactivated with Dulbecco's modified Eagle's medium containing 2% fetal bovine serum. After being washed three times, the pancreas was suspended in Dulbecco's modified Eagle's medium and placed into a 6-well plate. Islets were then handpicked under a microscope and infected with Ad-EGFP in a 6-well plate for 2 hours in serum-free medium (multiplicity of infection = 100, each islet was estimated to have 1,000 cells on average). Then, viruses were removed and the medium was replaced with fresh Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. After 24-hour incubation, the islets were harvested and encased with 200 μl of 1% agar in a 50 °C water bath. Islets were then processed as paraffin sections for immunostaining.
Immunofluorescence staining. For paraffin sections (4 μm), the immunostaining procedure has been described. 8 Briefly, after antigen retrieval with sodium citric solution (0.01 mol/l, pH 6.0) at 95 °C for 20 minutes, primary antibody (predetermined dilution plus 1% bovine serum albumin) incubation was carried out at 4 °C overnight. Staining for the secondary antibody was done at room temperature for 1 hour. After incubation, samples were washed three times with phosphate-buffered saline (5 minutes each wash). A volume of 10 μl of 4′,6-diamidino-2-phenylindole (1 μg/ml) was added to each sample after the last wash. One drop of mounting fluid was added to the sample before it was laid over with a cover slide and sealed with nail polish. Images were taken under a fluorescence microscope equipped with a CCD camera (Eclipse TE 2000; Nikon, Tokyo, Japan). For frozen sections (10 μm), antibody staining was performed as stated above without antigen retrieval.
Quantification of adenoviral transduction efficiency. To determine the transduction efficiency, the pancreatic body and tail were harvested and immunostaining was performed on five paraffin sections separated by 150 μm. Islets were considered positive when at least one of the islet cells expressed EGFP. A total of ~60 islets were evaluated for each animal. To determine the area on photomicrographs, the islet was circulated manually with Image J (NIH, Bethesda, MD). The cell number within an islet was calculated by dividing the islet area by the average area of a single islet cell. The EGFP-positive cells were determined according to the 4′,6-diamidino-2-phenylindole staining and the number was counted manually in each islet. The percentage of transduction for α and β cells was calculated only for positive islets. Islets with a size <30 μm were not counted.
Administration of STZ.
A density of 5 × 10 9 IU of Ad-EGFP or Ad-Sirt1 in 50 μl of saline solution was injected into the pancreases of Balb/c mice according to the procedure described above (C.T.). Mice were injected via peritoneum with STZ (195 mg/kg of body weight) dissolved in 0.1 mol/l sodium citrate buffer (pH 4.5) 48 hours postsurgery. Mice were analyzed for fasting plasma glucose or glucose tolerance before or after the administration of STZ. The pancreases were then harvested for determination of the relative β-cell mass.
Analysis of the relative islet cell mass. The relative islet cell mass of the pancreatic body and tail was estimated by hematoxylin and eosin staining. Briefly, each paraffin block of the pancreas was sectioned consecutively. A total of 10 slides (separated by 80 μm) were analyzed. To determine the area on photomicrographs, the islet was circulated manually with Image J (NIH). The relative islet cell mass was calculated as the sum of total islet areas.
Glucose homeostasis. After a 12-hour fast, blood sample from the tail vein was measured using a handheld glucometer (OneTouch Ultra; LifeScan, Milpitas, CA). For glucose tolerance test, mice were injected intraperitoneally with 2 g/kg of glucose after fasting. Blood was sequentially sampled at different time points from the tail vein and analyzed as above.
Statistical analysis. All data were presented as the mean value ± SD of each group. The Student's t-test was carried out by using GraphPad Prizm 5. P values <0.05 were considered statistically significant. Figure S1 . Transduction of the liver and spleen. Figure S2 . Transcript levels of transgenes in the pancreas, liver and spleen. Figure S3 . Nuclear translocation of NF-κB. Figure S4 . Measurement of beta-cell apoptosis. Figure S5 . Measurement of beta-cell survival. Figure S6 . Measurement of beta-cell function.
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